Showing results (1511-1520 of 1,614) with videos related to

Sort By:
Pageof 162
RSC Medicinal Chemistry|March 22, 2024
Stereoselective synthesis and antiproliferative activity of allo-gibberic acid-based 1,3-aminoalcohol regioisomersZein Alabdeen Khdar, Tam Minh Le, Zsuzsanna Schelz, et al.
RSC Medicinal Chemistry|March 22, 2024
Discovery of a new pyrido[2,3-d]pyridazine-2,8-dione derivative as a potential anti-inflammatory agent through COX-1/COX-2 dual inhibitionFernanda A Rosa, Davana S Gonçalves, Karlos E Pianoski, et al.
RSC Medicinal Chemistry|March 22, 2024
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studiesWei Zeng, Chi Han, Sarah Mohammed, et al.
RSC Medicinal Chemistry|September 30, 2024
Discovery of selective LATS inhibitors via scaffold hopping: enhancing drug-likeness and kinase selectivity for potential applications in regenerative medicineGuldana Issabayeva, On-Yu Kang, Seong Yun Choi, et al.
RSC Medicinal Chemistry|September 30, 2024
Development of naphthalimide hydrazide derivatives as potent antibacterial agents against carbapenem-resistant A. baumanniiPreeti Rana, Rahul Maitra, Deepanshi Saxena, et al.
RSC Medicinal Chemistry|September 18, 2024
A photoswitchable CENP-E inhibitor with single blue-green light to control chromosome positioning in mitotic cellsKazuya Matsuo, Takashi Kikukawa, Tomonori Waku, et al.
RSC Medicinal Chemistry|September 18, 2024
Preventing SARS-CoV-2 infection using Fv-antibodies targeting the proprotein convertase (PPC) cleavage siteJaeyong Jung, Jeong Soo Sung, Soonil Kwon, et al.
RSC Medicinal Chemistry|September 18, 2024
New ATP-competitive inhibitors of E. coli GyrB obtained from the mapping of the hydrophobic floor at the binding site: synthesis and biological evaluationLucas Gutierrez, Peter Peršolja, Rodrigo Tosso, et al.
RSC Medicinal Chemistry|September 16, 2024
Rational design and in vitro testing of new urease inhibitors to prevent urinary catheter blockageRachel A Heylen, Nicola Cusick, Tom White, et al.
RSC Medicinal Chemistry|September 16, 2024
Novel PROTAC probes targeting KDM3 degradation to eliminate colorectal cancer stem cells through inhibition of Wnt/β-catenin signalingShadid U Zaman, Piyusha P Pagare, Hongguang Ma, et al.
Pageof 162